News Sentiment

FLGT sentiment intelligence

Fulgent Genetics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 61 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Diagnostics & Research Read-through group
Latest close 20.55 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

79/100 classification confidence.

Company focus 61

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend inactive

-1.4% over one week, +10.0% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

ETFs Investing in Fulgent Genetics, Inc. Stocks

Market Reaction

Balanced read

60/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 79/100 classification
One-week reaction -1.4% Price digesting
Trend fit Trend inactive 10.0% over four weeks
Fair value -7.8% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 48
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 61
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 12
Stock Titan 6
TradingKey 6
Business Wire 4
Market source 4
Seeking Alpha 3
Stock Traders Daily 3
MarketBeat 2

Event Lens

What the news is about

Classified themes
Market update 32
Earnings 19
Analyst action 6
Guidance 2
Regulatory and legal 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 61
TradingView Direct company coverage

ETFs Investing in Fulgent Genetics, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of Fulgent Genetics, Inc. (FLGT). The ETFs are sorted by their market value of FLGT holdings and include details such as issuer, management style, focus, expense ratio, AUM, price, change, relative volume, a

Tone
Neutral 50/100
Event
Market update
Published
14 Jul 2026 01:41
Source
TradingView
MarketBeat Direct company coverage

Y Intercept Hong Kong Ltd Invests $1.08 Million in Fulgent Genetics, Inc. $FLGT

Y Intercept Hong Kong Ltd recently invested $1.08 million in Fulgent Genetics, acquiring 67,697 shares, representing a 0.23% stake in the company. Institutional ownership remains significant at 48.06%, despite recent insider sales by COO Jian Xie and insider Hanlin Gao. Analyst c

Tone
Neutral 50/100
Event
Analyst action
Published
12 Jul 2026 18:10
Source
MarketBeat
Stock Traders Daily Direct company coverage

(FLGT) Movement Within Algorithmic Entry Frameworks

This article analyzes Fulgent Genetics Inc. (FLGT) using algorithmic frameworks. It highlights strong near to mid-term sentiment, a weak long-term outlook, and an exceptional risk-reward setup targeting a 27.8% gain. The piece also details specific institutional trading strategie

Tone
Positive 66/100
Event
Guidance
Published
07 Jul 2026 10:09
Source
Stock Traders Daily
Finviz Direct company coverage

FLGT - Fulgent Genetics Inc Forecast, Target Price

This article provides a detailed financial overview and forecast for Fulgent Genetics Inc (FLGT). It includes key metrics such as market capitalization, income, sales, earnings per share, and stock performance indicators. The report also highlights analyst recommendations and a t

Tone
Negative 40/100
Event
Analyst action
Published
03 Jul 2026 11:10
Source
Finviz
TradingView Direct company coverage

Enterprise value to EBITDA forward of Fulgent Genetics, Inc. – NASDAQ:FLGT

This article provides access to the enterprise value to EBITDA forward data for Fulgent Genetics, Inc. (NASDAQ: FLGT) via the TradingView platform. It navigates through the financial metrics available for the company within the health services sector. The content primarily focuse

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 00:40
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Fulgent Genetics, Inc. – NASDAQ:FLGT

This article displays financial information for Fulgent Genetics, Inc. (NASDAQ: FLGT), focusing on its forward price-to-earnings ratio. The content is presented on a financial data platform, providing a snapshot of the company's valuation metric. It confirms that the market was c

Tone
Neutral 50/100
Event
Earnings
Published
30 Jun 2026 00:41
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBIT forward of Fulgent Genetics, Inc. – NASDAQ:FLGT

This article presents financial information for Fulgent Genetics, Inc. (NASDAQ:FLGT), focusing on its enterprise value to EBIT forward metric. It appears to be a stub or preview from a financial data platform, providing a title but no detailed content beyond company identificatio

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 02:39
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBIT forward of Fulgent Genetics, Inc. – BMV:FLGT

This article focuses on the enterprise value to EBIT forward metric for Fulgent Genetics, Inc. (BMV:FLGT). The content appears to be a financial data page from TradingView, offering an overview of the company's financial performance. It provides no analytical text but lists the m

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 19:10
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Fulgent Genetics, Inc. – BMV:FLGT

The article provides financial information for Fulgent Genetics, Inc. (BMV:FLGT), specifically focusing on its price-to-sales forward ratio. It seems to be a financial data snippet from TradingView, indicating the market status and offering various tools and resources related to

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 11:41
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Fulgent Genetics, Inc. – NASDAQ:FLGT

The article focuses on the enterprise value to revenue forward metric for Fulgent Genetics, Inc. (NASDAQ:FLGT). It appears to be a financial data snippet or a specific analytical view provided by TradingView, detailing a specific metric for the company.

Tone
Neutral 50/100
Event
Earnings
Published
28 Jun 2026 09:09
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Fulgent Genetics, Inc. – BMV:FLGT

This article provides the "Price to earnings forward" metric for Fulgent Genetics, Inc. (BMV:FLGT). It indicates that the market was closed with no trades when the information was accessed. The content is presented within the context of TradingView's financial data platform.

Tone
Neutral 50/100
Event
Earnings
Published
28 Jun 2026 07:09
Source
TradingView
TradingView Direct company coverage

Fulgent Genetics, Inc. Actuals & Estimates (NASDAQ:FLGT)

This article provides comprehensive financial data and analyst estimates for Fulgent Genetics, Inc. (NASDAQ: FLGT), covering income statements, balance sheets, cash flow, and valuation metrics. It highlights the stock's recent performance, including a 0.82% increase in the last 2

Tone
Neutral 50/100
Event
Analyst action
Published
26 Jun 2026 14:09
Source
TradingView
Stock Traders Daily Direct company coverage

How (FLGT) Movements Inform Risk Allocation Models

This article analyzes Fulgent Genetics Inc. (FLGT) using AI models to inform risk allocation. It highlights a positive near-term sentiment with potential for a broader shift, identifying specific support and resistance levels. The piece also outlines three distinct institutional

Tone
Positive 72/100
Event
Market update
Published
26 Jun 2026 09:09
Source
Stock Traders Daily
TradingView Direct company coverage

FLGT Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for Fulgent Genetics, Inc. (FLGT). It includes analyst ratings, historical stock performance, key financial metrics, and upcoming earnings dates. The current stock price is $19.44, with analysts' maximum and minimum price targets

Tone
Neutral 50/100
Event
Analyst action
Published
26 Jun 2026 01:40
Source
TradingView
Market source Direct company coverage

Fulgent Genetics (FLGT) Stock Faces Mixed Analyst Target Changes After Margin Questions

Analysts are maintaining Fulgent Genetics' (FLGT) fair value at US$15.00, indicating that core valuation frameworks remain stable despite recent changes in expectations around execution risk. While some analysts remain bullish due to intact business model assumptions, Piper Sandl

Tone
Neutral 50/100
Event
Analyst action
Published
25 Jun 2026 06:07
Source
Market source
TradingKey Direct company coverage

Fulgent Genetics Inc (FLGT) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Fulgent Genetics Inc (FLGT), noting its current valuation score of 9.04 and ranking within the Healthcare Providers & Services industry. It highlights the company's P/E ratio, comparing it to recent highs and lows, and indicates that

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 07:10
Source
TradingKey
TradingKey Direct company coverage

Fulgent Genetics Inc (FLGT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Fulgent Genetics Inc (FLGT), detailing its current price momentum score, support and resistance levels, and indicator readings. It presents a summary of various technical indicators like MACD, RSI, and moving averages (MA5 to MA200),

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 04:09
Source
TradingKey
TradingKey Direct company coverage

Fulgent Genetics Inc (FLGT) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Fulgent Genetics Inc (FLGT), highlighting its current earnings forecast score, average price target of $35.00, and analyst rating as "Hold." It also gives details on expected revenue, EPS for the next quarter, and peer comparisons wi

Tone
Neutral 50/100
Event
Earnings
Published
22 Jun 2026 01:10
Source
TradingKey
TradingKey Direct company coverage

Fulgent Genetics Inc (FLGT) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Fulgent Genetics Inc (FLGT) including its current stock price, market capitalization, and financial performance metrics. It specifically highlights that the company has not distributed any dividends over the past five years and lists that ther

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 20:39
Source
TradingKey
TradingKey Direct company coverage

Fulgent Genetics Inc (FLGT) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Fulgent Genetics Inc (FLGT), listing major individual and institutional holders and their respective proportions. It also presents institutional shareholding trends over several quarters and shows the company's inclusion in variou

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 20:39
Source
TradingKey
TradingKey Direct company coverage

Fulgent Genetics Inc (FLGT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Fulgent Genetics Inc (FLGT), categorized by business segments and geographic regions. For FY2023, the company's revenue distribution shows that the institutional segment contributes the most, followed by insurance and patient

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 20:39
Source
TradingKey
TMX Newsfile Direct company coverage

Fulgent Deadline Alert

Faruqi & Faruqi, LLP is investigating potential claims against Fulgent Genetics, Inc. (NASDAQ: FLGT) and reminds investors of the November 21, 2022 deadline to seek the role of lead plaintiff in a federal securities class action. The lawsuit alleges that Fulgent engaged in medica

Tone
Negative 28/100
Event
Regulatory and legal
Published
14 Jun 2026 17:39
Source
TMX Newsfile
Finviz Direct company coverage

FLGT - Fulgent Genetics Inc Stock Price and Quote

This article provides a detailed financial overview and news compilation for Fulgent Genetics Inc (FLGT). It includes the latest stock close, market capitalization, key financial ratios, insider transaction details, and a chronological list of recent news and analyst ratings. The

Tone
Neutral 50/100
Event
Analyst action
Published
05 Jun 2026 13:41
Source
Finviz
Stock Traders Daily Direct company coverage

How Fulgent Genetics Inc. (FLGT) Affects Rotational Strategy Timing

Fulgent Genetics Inc. (FLGT) is showing strong near and mid-term sentiment but a weak long-term outlook, with an exceptional risk-reward short setup targeting a significant downside. AI models have generated distinct trading strategies, including position trading, momentum breako

Tone
Neutral 50/100
Event
Guidance
Published
04 Jun 2026 06:09
Source
Stock Traders Daily